Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Change in Accured Expenses: 2009-2025

Historic Change in Accured Expenses for Prestige Consumer Healthcare (PBH) over the last 17 years, with Sep 2025 value amounting to $4.7 million.

  • Prestige Consumer Healthcare's Change in Accured Expenses rose 79.05% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year increase of 366.81%. This contributed to the annual value of $7.0 million for FY2025, which is 143.07% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Change in Accured Expenses of $4.7 million as of Q3 2025, which was up 682.53% from -$813,000 recorded in Q2 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Change in Accured Expenses registered a high of $18.4 million during Q2 2021, and its lowest value of -$23.1 million during Q1 2021.
  • Moreover, its 3-year median value for Change in Accured Expenses was $2.4 million (2023), whereas its average is -$264,818.
  • Per our database at Business Quant, Prestige Consumer Healthcare's Change in Accured Expenses skyrocketed by 379.42% in 2023 and then plummeted by 453.98% in 2024.
  • Prestige Consumer Healthcare's Change in Accured Expenses (Quarterly) stood at -$9.5 million in 2021, then soared by 84.84% to -$1.4 million in 2022, then surged by 379.42% to $4.0 million in 2023, then fell by 6.37% to $3.8 million in 2024, then soared by 79.05% to $4.7 million in 2025.
  • Its Change in Accured Expenses was $4.7 million in Q3 2025, compared to -$813,000 in Q2 2025 and $2.6 million in Q1 2025.